The weekly litigation news digest is live. Subscribe now

IP Verse

Arginine And Its Use As A T Cell Modulator - EP3525775

The patent EP3525775 was granted to Institute FOR Research IN Biomedicine on Jun 7, 2023. The application was filed on Oct 12, 2017 under application number EP17791612A. The patent is currently recorded with a legal status of "Revoked".

EP3525775

INSTITUTE FOR RESEARCH IN BIOMEDICINE
Application Number
EP17791612A
Filing Date
Oct 12, 2017
Status
Revoked
Dec 20, 2024
Publication Date
Jun 7, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
HAMPTON KNOWLESMar 7, 2024D YOUNGADMISSIBLE
COHAUSZ & FLORACK PATENT UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBBJan 25, 2024COHAUSZ & FLORACKADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2012019127
OPPOSITIONCN104818248
OPPOSITIONUS2004057926
OPPOSITIONUS5576351
OTHEREP3525775

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents